Cargando…
Structural insights into SARS-CoV-2 infection and therapeutics development
The current COVID-19 pandemic is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). By late October 2020, more than 43 million cases of infections, including over 1.15 million deaths, have been confirmed worldwide. This review focuses on our current understanding of SARS-CoV...
Autores principales: | Sun, Gangyu, Xue, Lulu, He, Qingjing, Zhao, Yue, Xu, Wenqing, Wang, Zhizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985237/ https://www.ncbi.nlm.nih.gov/pubmed/33550140 http://dx.doi.org/10.1016/j.scr.2021.102219 |
Ejemplares similares
-
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020) -
Structural biology of SARS-CoV-2 and implications for therapeutic development
por: Yang, Haitao, et al.
Publicado: (2021) -
Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2
por: Shahid, Munazza, et al.
Publicado: (2021) -
Structural insights into SARS-CoV-2 proteins
por: Arya, Rimanshee, et al.
Publicado: (2021) -
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)